TR200200987T2 - Kanser tedavisine yönelik,ornatılmış pirroller - Google Patents

Kanser tedavisine yönelik,ornatılmış pirroller

Info

Publication number
TR200200987T2
TR200200987T2 TR2002/00987T TR200200987T TR200200987T2 TR 200200987 T2 TR200200987 T2 TR 200200987T2 TR 2002/00987 T TR2002/00987 T TR 2002/00987T TR 200200987 T TR200200987 T TR 200200987T TR 200200987 T2 TR200200987 T2 TR 200200987T2
Authority
TR
Turkey
Prior art keywords
cancer treatment
treating
substituted pyrroles
cancer
controlling
Prior art date
Application number
TR2002/00987T
Other languages
English (en)
Inventor
Fotouhi Nader
Kong Norman
Aijun Liu Emily
John Lovey Alley
Guilfoyle Jr.Mullin John
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR200200987T2 publication Critical patent/TR200200987T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Abstract

Asagidaki (I) formülüne sahip ornatilmis yeni pirroller anlatilmistir. Bu bilesikler ve bunlarin ilaç sanayiinde kullanilmaya uygun tuzlari, hastalara sürekli infüzyon çözeltileri olarak verilmeye uygundur ve bunlar, asiri hücre çogalmasina bagli bozukluklarin, özellikle de kanserin tedavi edilmesinde ve/ya da kontrol altina alinmasinda yararlidir. Diger yanda bu bulusta, yukarida söz edilen bilesikleri içeren ilaç bilesimleri ve bunlarin, kanserin tedavi edilmesine ve/ya da kontrol altina alinmasina yönelik kullanimlari da anlatilmistir.
TR2002/00987T 1999-10-12 2000-10-02 Kanser tedavisine yönelik,ornatılmış pirroller TR200200987T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15886099P 1999-10-12 1999-10-12

Publications (1)

Publication Number Publication Date
TR200200987T2 true TR200200987T2 (tr) 2002-09-23

Family

ID=22570037

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00987T TR200200987T2 (tr) 1999-10-12 2000-10-02 Kanser tedavisine yönelik,ornatılmış pirroller

Country Status (30)

Country Link
EP (1) EP1224181B1 (tr)
JP (1) JP2003511449A (tr)
KR (1) KR20020038817A (tr)
CN (1) CN1155595C (tr)
AR (1) AR026004A1 (tr)
AT (1) ATE255576T1 (tr)
AU (1) AU781732B2 (tr)
BR (1) BR0014680A (tr)
CA (1) CA2385071A1 (tr)
CZ (1) CZ20021610A3 (tr)
DE (1) DE60006990T2 (tr)
DK (1) DK1224181T3 (tr)
ES (1) ES2210005T3 (tr)
HK (1) HK1050533A1 (tr)
HR (1) HRP20020262B1 (tr)
HU (1) HUP0203558A3 (tr)
IL (1) IL148815A0 (tr)
MA (1) MA26830A1 (tr)
MX (1) MXPA02003667A (tr)
NO (1) NO20021718D0 (tr)
NZ (1) NZ518038A (tr)
PE (1) PE20010695A1 (tr)
PL (1) PL357441A1 (tr)
PT (1) PT1224181E (tr)
RU (1) RU2002110111A (tr)
TR (1) TR200200987T2 (tr)
TW (1) TWI230708B (tr)
WO (1) WO2001027106A1 (tr)
YU (1) YU25202A (tr)
ZA (1) ZA200202231B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US7776855B2 (en) 2006-07-27 2010-08-17 Janssen Pharmaceutica N.V. Antimicrobial oxazolidinone prodrugs
EP2445343B1 (en) * 2009-06-25 2021-08-04 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds
UY34072A (es) * 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
US20150284364A1 (en) 2012-11-07 2015-10-08 Nicole Bieri Substituted indole derivatives
EP3771711A1 (en) 2019-07-29 2021-02-03 Bayer Animal Health GmbH Pyrazole derivatives for controlling arthropods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
ID26353A (id) * 1998-03-17 2000-12-14 Hoffmann La Roche Bisindolimaleimida tersubstitusi untuk inhibisi proliferasi sel

Also Published As

Publication number Publication date
CN1378545A (zh) 2002-11-06
HUP0203558A3 (en) 2004-01-28
YU25202A (sh) 2004-12-31
PL357441A1 (en) 2004-07-26
NZ518038A (en) 2004-02-27
EP1224181B1 (en) 2003-12-03
DK1224181T3 (da) 2004-04-13
NO20021718L (no) 2002-04-11
EP1224181A1 (en) 2002-07-24
AU7911600A (en) 2001-04-23
KR20020038817A (ko) 2002-05-23
DE60006990T2 (de) 2004-10-28
BR0014680A (pt) 2002-06-11
DE60006990D1 (de) 2004-01-15
NO20021718D0 (no) 2002-04-11
ZA200202231B (en) 2003-06-19
RU2002110111A (ru) 2003-12-20
ATE255576T1 (de) 2003-12-15
MA26830A1 (fr) 2004-12-20
HK1050533A1 (en) 2003-06-27
CN1155595C (zh) 2004-06-30
AU781732B2 (en) 2005-06-09
TWI230708B (en) 2005-04-11
HUP0203558A2 (hu) 2003-02-28
IL148815A0 (en) 2002-09-12
JP2003511449A (ja) 2003-03-25
PT1224181E (pt) 2004-04-30
PE20010695A1 (es) 2001-07-05
HRP20020262A2 (en) 2004-04-30
HRP20020262B1 (en) 2005-06-30
WO2001027106A1 (en) 2001-04-19
AR026004A1 (es) 2002-12-26
CZ20021610A3 (cs) 2002-10-16
MXPA02003667A (es) 2002-08-30
ES2210005T3 (es) 2004-07-01
CA2385071A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
IS6647A (is) Kínasólínafleiður til að meðhöndla æxli
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
HK1042479A1 (en) 2-Amino-6-anilino-purines and their use as medicaments.
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
TR199901417T2 (tr) Analjezik etkisi olan yeni bilesimler.
ATE248837T1 (de) Chinuclidin-acrylamide
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
ATE243196T1 (de) Piperidine und pyrrolidine
HK1063185A1 (en) Quinoline derivatives and their use as tyrosine kinase inhibitors
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
SE9802937D0 (sv) Novel compounds
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
IL147890A0 (en) Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
YU46302A (sh) Supstituisani piroli
HK1050203A1 (en) Novel fusidic acid derivatives.